Results 161 to 170 of about 116,059 (245)

The Pathological Role of LDL in Membranous Nephropathy and Diabetic Nephropathy and the Protective Efficacy of LDL Apheresis: A Narrative Review. [PDF]

Toxins (Basel)
Kodama G, Taguchi K, Wada Y, Nakano K, Shibata R, Fukami K.   +5 more
europepmc   +1 more source

Análise da variação da taxa de internações hospitalares para tratamento de edema, proteinúria e transtornos hipertensivos na gravidez, parto e puerpério antes e durante a pandemia de Covid-19 em todas as regiões do Brasil

Gabriela Vitória Giovanoni, Eduarda Mendes Lopes, Bruno Bibiano de Oliveira, Bruno Edgar Picolli, Stephany Bitencurt Chagas Araujo, Isadora Barreta Spagnol, Ana Paula Backes Dos Anjos, Rafael Rauber, Victória Pacheco Kannenberg, Fabiola Zancan Lazzari, Vitória Loss, Marcela Scussel Pavan   +11 more
openalex   +2 more sources

Optimizing Prolonged (6 h) Normothermic Machine Perfusion of Donor Kidneys (PROPER Study)

Artificial Organs, EarlyView.
Prolonged ex situ normothermic machine perfusion of donor kidneys up to 6 h is feasible, maintaining viability and histological integrity. Key protocol optimizations include fresh red blood cells, albumin supplementation, and urine recirculation—laying the groundwork for assessment and potential pretransplant interventions in future clinical trials ...
Asel S. Arykbaeva, Veerle A. Lantinga, L. Leonie van Leeuwen, Marten Engelse, Ton J. Rabelink, Jesper Kers, Jason B. Doppenberg, Volkert A. L. Huurman, Robert A. Pol, Robert C. Minnee, Henri G. D. Leuvenink, Rutger J. Ploeg, Cyril Moers, Dorottya K. de Vries, Ian P. J. Alwayn   +14 more
wiley   +1 more source

Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry. [PDF]

Lupus Sci Med
Vidal-Montal P, Fabregat A, Altabás-González I, Pego-Reigosa JM, Hernández-Martínez A, Rua-Figueroa I, Salman-Monte T, Moriano C, Tejera Segura B, Vela P, Pareja-Martínez A, García-Cirera S, García-Villanueva MJ, Garrote-Corral S, Heredia S, Riancho-Zarrabeitia L, Manrique-Arija S, Bernárdez J, Magallares B, Torrente-Segarra V, Frade-Sosa B, Gómez-Puerta JA, Martinez-Barrio J, Narvaez J, BELIMUMAB Multicenter Spanish Register Group (BEL-SPAIN).   +24 more
europepmc   +1 more source

Classificação da proteinúria em cães que realizaram urinálise em Manaus

Afonso Sousa, R Nascimento, Amanda Paula Ferreira Danin   +2 more
openalex   +1 more source

The Complement System in Post‐Transplant Kidney Injury

Organ Medicine, EarlyView.
Mengsi Hu
wiley   +1 more source

Tubulointerstitial nephritis and uveitis syndrome in children: What to keep an eye on

Acta Ophthalmologica, EarlyView.
Abstract Purpose The purpose of this study was to determine the disease course in patients with tubulointerstitial nephritis and uveitis (TINU) syndrome, focusing on long‐term outcome and the incidence of complications such as chronic kidney disease (CKD).
Jytte Hendrikse, Anne Sina Paula Simon, Viera Kalinina Ayuso, Joke Helena de Boer, Gerrit van den Berg   +4 more
wiley   +1 more source

A retrospective single-center cohort study of major subtypes of primary glomerular diseases (MN, IgAN, and MCD): clinical characteristics, prognostic outcomes, and risk factors. [PDF]

Front Med (Lausanne)
Zhang W, Dai Y, Zhang W, Wang Y, Wang L.
europepmc   +1 more source

Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection—General and Special Populations

Alimentary Pharmacology &Therapeutics, EarlyView.
Current first‐line NUCs show comparable renal safety profiles in CHB patients with no or mild kidney dysfunction, with growing evidence that favours TAF. Future prospective studies are needed to validate these findings, and more research should focus on CHB patients with diabetes mellitus who are at risk of CKD.
Lung‐Yi Mak, Tsung‐Hui Hu, Desmond Y. H. Yap   +2 more
wiley   +1 more source

Emerging Therapies in IgA Nephropathy: From A Proliferation-Inducing Ligand (APRIL) and B-cell Activating Factor (BAFF) Inhibitors to Precision Medicine. [PDF]

Cureus
Sharma I, Panta R.
europepmc   +1 more source